Global funding for research and development on neglected diseases reached a historic low in 2015, driven by declining public sector investment. The G-FINDER report by Australia-based independent group, Policy Cures Research, says that the decline is due to the lack of funding by rich countries. According to it, this is the lowest-ever funding on record by the US. Same can be said of the UK. The G-FINDER analysis tracks public and private investment in diseases that affect people in the developing countries. Over 1 billion people in 149 countries worldwide suffer from one or more neglected diseases, and they are now included in the Sustainable Development Goals.
